Common mistakes to avoid when investing in mutual funds

 

When investing in mutual funds, there are several common mistakes and practices to avoid in order to make sound investment decisions and maximize your returns. Here are some "what not to do" guidelines in mutual fund investing:

  1. Not Setting Clear Financial Goals: Avoid investing in mutual funds without a clear understanding of your financial goals. Determine why you are investing, whether it's for retirement, education, a home purchase, or another objective.

  2. Ignoring Risk Tolerance: Don't invest in funds that are too risky or too conservative for your risk tolerance. Assess your risk tolerance honestly and choose funds that align with it.

  3. Market Timing: Avoid trying to time the market. Timing the market is extremely difficult and often leads to poor results. Instead, focus on a long-term investment strategy.

  4. Frequent Trading: Avoid excessive trading or trying to "chase" short-term market trends. Frequent trading can lead to higher transaction costs and capital gains taxes.

  5. Ignoring Costs: Don't ignore the expenses associated with mutual funds. High expense ratios can erode your returns over time. Look for funds with reasonable costs.

  6. Overlooking Diversification: Not diversifying your investments is a common mistake. Diversification helps spread risk. Avoid putting all your money into a single fund or asset class.

  7. Ignoring Asset Allocation: Asset allocation is crucial. Avoid allocating your assets in a way that's not in line with your investment goals and risk tolerance. Properly balance your investments between equities, bonds, and other asset classes.

  8. Chasing Performance: Avoid investing in a fund solely because it has recently performed well. Past performance is not a reliable indicator of future results.

  9. Neglecting Research: Don't invest in funds without doing thorough research. Review the fund's prospectus, historical performance, and the fund manager's experience.

  10. Not Monitoring Your Investments: Don't forget to periodically review and rebalance your portfolio. Market conditions change, and your asset allocation may drift from your desired mix over time.

  11. Panic Selling: Avoid making impulsive decisions during market downturns. Panic selling when the market is down can lead to significant losses. Stick to your investment strategy.

  12. Not Considering Tax Implications: Failing to consider the tax consequences of your investments can lead to unexpected tax bills. Understand the tax implications of your mutual fund holdings.

  13. Relying Solely on One Fund: Avoid putting all your investments in a single mutual fund, even if it's a well-regarded fund. Diversify across different funds and asset classes.

  14. Not Consulting a Financial Advisor: If you are unsure about your investment choices, don't hesitate to seek advice from a qualified financial advisor who can provide personalized guidance.

  15. Neglecting Changes in Your Financial Situation: Your financial situation can change over time, so don't forget to adjust your investment strategy as needed.

Remember that mutual fund investing should be part of a broader financial plan, and it's important to stay informed, diversify your investments, and maintain a long-term perspective. Making informed, well-considered decisions is key to successful mutual fund investing


How to choose a fund

  1. Alignment with Financial Goals: When a fund aligns with your financial goals, risk tolerance, and investment horizon, it is more likely to help you achieve your specific objectives, whether they are long-term wealth accumulation, retirement planning, or funding a major expense like a home purchase or education.

  2. Risk Management: Funds that meet your risk tolerance ensure you don't take on more risk than you are comfortable with. This can prevent panic selling during market downturns and help you stay invested for the long term.

  3. Diversification: Funds that offer diversification spread your risk across different asset classes, reducing the impact of a poor-performing investment. A well-diversified fund can help stabilize your portfolio and reduce overall risk.

  4. Cost Efficiency: Funds with lower expense ratios minimize the impact of fees on your returns over time, leaving more of your money invested and working for you.

  5. Professional Management: Funds with experienced and skilled fund managers can make informed investment decisions, potentially outperforming the market and helping you achieve better returns.

  6. Tax Efficiency: Funds that consider tax implications can help you minimize the tax burden on your investments, potentially saving you money in the long run.

  7. Historical Performance: While past performance doesn't guarantee future results, a fund that has demonstrated consistent performance in various market conditions can provide you with confidence that the fund's strategy is effective.

  8. Exit Load and Liquidity: Understanding the fund's exit load or redemption fee can help you avoid unnecessary charges, and a fund with good liquidity allows you to easily buy or sell your shares.

Top 10 Indian companies with high market cap and consistent growth

 

Here are the top 10 Indian companies with high market capitalization and consistent growth

  1. Reliance Industries Limited (RIL): RIL is India's largest private sector company by market capitalization, with a market cap of over INR 14 trillion. The company operates in various sectors, including oil and gas, petrochemicals, retail, and telecommunications.

  2. Tata Consultancy Services Limited (TCS): TCS is the largest software services company in India, with a market cap of over INR 13 trillion. The company provides IT services, digital, and business solutions to clients across various industries.

  3. HDFC Bank Limited: HDFC Bank is one of India's largest private sector banks, with a market cap of over INR 8 trillion. The bank provides a wide range of financial products and services to retail and corporate customers.

  4. Infosys Limited: Infosys is a global leader in technology and consulting services, with a market cap of over INR 6.5 trillion. The company provides software development, maintenance, and independent validation services to clients across various industries.

  5. Housing Development Finance Corporation Limited (HDFC): HDFC is one of India's largest housing finance companies, with a market cap of over INR 5.5 trillion. The company provides various financial products and services related to housing and real estate.

  6. ICICI Bank Limited: ICICI Bank is one of India's largest private sector banks, with a market cap of over INR 5 trillion. The bank provides a wide range of financial products and services to retail and corporate customers.

  7. Kotak Mahindra Bank Limited: Kotak Mahindra Bank is a private sector bank with a market cap of over INR 3.5 trillion. The bank provides various financial products and services to retail and corporate customers.

  8. Bajaj Finance Limited: Bajaj Finance is a non-banking financial company (NBFC) with a market cap of over INR 3.5 trillion. The company provides a wide range of financial products and services, including consumer finance, SME finance, and commercial lending.

  9. Hindustan Unilever Limited (HUL): HUL is India's largest consumer goods company, with a market cap of over INR 3.2 trillion. The company offers various consumer products, including personal care, home care, and foods and beverages.

  10. State Bank of India (SBI): SBI is India's largest public sector bank, with a market cap of over INR 2.5 trillion. The bank provides a wide range of financial products and services to retail and corporate customers.

Pidilite Industries: Building a Better Future: The Success Story of Pidilite Industries

 

Pidilite Industries Limited is an Indian multinational company that is primarily engaged in the manufacture of adhesives, sealants, construction chemicals, and other industrial chemicals. The company was founded in 1959 by Balvant Parekh and has its headquarters in Mumbai, India.

Pidilite's most well-known brand is Fevicol, which is the largest selling adhesive in India and has become synonymous with adhesives in the country. The company's other popular brands include M-Seal, Fevikwik, Fevistik, and Dr. Fixit.

Apart from adhesives and sealants, Pidilite Industries also produces a wide range of industrial chemicals such as synthetic resins, organic pigments, and surfactants. The company's products are used in various industries such as construction, automotive, packaging, textiles, and woodworking, among others.

Pidilite Industries has a strong presence not only in India but also in other countries such as the United States, the United Kingdom, Brazil, Thailand, and the Middle East. The company is known for its innovative and high-quality products and has won several awards for its performance and sustainability initiatives.

 Pidilite Industries fundamental data

 

  • Market Capitalization: INR 1.2 trillion (approx. USD 16.5 billion)
  • Revenue: INR 9,611 crore (approx. USD 1.3 billion)
  • Net Profit: INR 1,549 crore (approx. USD 211 million)
  • Earnings per share (EPS): INR 13.85
  • Price to Earnings (P/E) Ratio: 73.18
  • Return on Equity (ROE): 24.76%
  • Debt to Equity Ratio: 0.17
  • Dividend Yield: 0.28%

It's worth noting that these figures are subject to change depending on the company's performance and the prevailing market conditions.

Buy or sell?

Pidilite Industries is a well-established company with a strong brand reputation, a diverse product portfolio, and a global presence. The company has a dominant market position in India and is expanding its international operations. Moreover, Pidilite has a track record of innovation and continuous product development, which is essential for staying competitive in the industry.

On the other hand, it's important to note that the company operates in a highly competitive market, and there are always risks associated with investing in the stock market. The price of Pidilite Industries' stock may fluctuate depending on various factors such as economic conditions, changes in government policies, currency fluctuations, and competition.

Therefore, before making any investment decision, it's important to consider your investment objectives, risk tolerance, and consult a financial advisor. You should also conduct thorough research on the company's financial performance, market trends, and other relevant factors before making any investment decision.

Procter & Gamble Hygiene and Health Care Ltd

Procter & Gamble Hygiene and Health Care Ltd

P&G Hygiene and Health Care is one of India's fastest growing Fast Moving Consumer Goods Companies incorporated on 20th July 1964. Earlier known as Richardson Hindustan (RHL), in 1964 company received Industrial License to undertake manufacture of Menthol and de-mentholised peppermint oil and VICKS range of products such as Vicks VapoRub, Vicks Cough Drops and Vicks Inhaler.
Later in the year 1967 RHL introduced CLEARASIL, back then America's number one pimple cream. In 1985 RHL became affiliate of The Procter & Gamble Company, USA.
In 1989 the name of the company was changed to Procter & Gamble India and launched sanitary napkin under the name Whisper bringing a sudden change in Indian feminine hygiene category.
In June 2002, Procter & Gamble Hygiene & Health Care announced the launch of New Improved Vicks VapoRub – India’s Number One Cold Rub – that provides multi-symptom relief from the six symptoms of a child’s cold, namely – blocked nose, cough, body ache, headache, muscle-stiffness and breathing difficulty.
In July 2002, Procter & Gamble announced the launch of Vicks Action500+ Night tablets, a specially designed cold medicine that gives consumers multi-symptom relief from bothersome cold symptoms like headache and breathing difficulty, hence allowing restful sleep at night.
In October 2002, India’s number one cough and cold brand – Vicks – celebrated its 50th Year in India and launched Dual Golden Jubilee Offers to reward Indian consumers for 50 Years of trust and loyalty.
Globally Procter & Gamble owns brands like Duracell, Olay, Tide, Gillette, Braun, Pringles, Lacoste, Puma, Oral-B, HUGO, Mr.Clean, Cover Girl, Pantene Pampers ,Old spice are amongst others. Currently P&G Hygiene and Health has portfolio of brands such as Vicks & Whisper.
Products
Vicks- It is India’s No.1 Cough and Cold Brand. It created the cold & cough over-the-counter (OTC) category in India way back in 1952 and has led the category till date. Under this brand it has introduced products namely Vicks Action500+, Vicks VapoRub, Vicks Cough Drops, Vicks Formula 44 Cough Syrup and Vicks Inhaler.
Whisper- Under this it has introduced products for feminine hygiene. It has introduced products such as Whisper Maxi Regular, Whisper Maxi XL Wings, Whisper Ultra with Wings and Whisper Choice.
Awards and recognition
Vicks was rated as ‘India’s Most Trusted Brand’ by the ‘Advertising & Marketing’ Magazine
P&G Hygiene and Health Care was voted India's Best Employer 2003 in a survey of 200 companies conducted by International HR Consultancy Hewitt Associates in association with Business Today magazine.

Market Cap: 32,337 Cr.
Current Price: 9,962
52 weeks High / Low 11000.00 / 8714.00
Book Value: 248.15
Stock P/E: 80.21
Dividend Yield: 0.40 %
ROCE: 89.10 %
ROE: 56.85 %
Sales Growth (3Yrs): 1.71 %
Listed on BSE and NSE
Company Website
Face Value: 10.00


Industry PBV:
EPS: 124.19
Graham: 832.71
Debt to equity: 0.00
Book value: 248.15
Price to Earning: 80.21
PEG Ratio: 6.27
Earning Power: 43.79 %
Return on equity: 56.85 %
Pledged percentage: 0.00 %
Intrinsic Value: 12,452
Industry PE:
Piotroski score: 8.00
Volume: 1,198
Market cap to quarterly profit: 224.39
Market Capitalization: 32,337 Cr.
Price to book value: 40.15
Return on assets: 52.87 %
Debt: 0.00 Cr.
Interest Coverage Ratio: 118.20
Promoter holding: 70.64 %
Unpledged promoter holding: 70.64 %
Sales last year: 2,455 Cr.

Pfizer

Pfizer

Pfizer came to India in 1950 through a company named Dumex. Its first production unit was set up at Darukhanna in Mumbai. It manufactured products like Protinex, Isonex, Becosules and Corex.In the year 1960, the company set up one more plant at Thane, near Mumbai for manufacturing and conducting product research. In 1965 Pfizer entered into a licence agreement with Pfizer Corporation for the use of Pfizer’s processes, technical know-how, etc to manufacture its existing products. Later in the year 1992, Dumex was amalgamated with Pfizer.
In India, Pfizer instituted the first ever Disease Management Programme -- Healthy Heart in Cardio Vascular Disease (Hypertension, Chronic Stable Angina and Dyslipidemia), in partnership with Apollo Hospital, Hyderabad and Apollo Hospital, Chennai 
Six Pfizer brands feature among the Top 100 pharmaceutical brands in India, while two of Pfizer India's brands -- Corex (Cough Formulation) and Becosules (Multivitamin) -- continue to rank among the Top 15 pharmaceutical drug brands
The company’s manufacturing plant was ISO 14001 certified for its Environment Management System awarded by DNV Certification B.V, Netherlands.
In 2013 Pfizer Ltd and Wyeth Ltd decided to merge, creating a single Pfizer Brand.
Products
Prescription Drugs- Pfizer manufactures prescription drugs such as Viagra, Lyrica, Viagra, Dolonex Gel, Ponstan, Citralka Liquid, and many more.
Consumer Health- It produces over the counter formulations and drugs such as Benadryl cough, Coolmint Listerine Mouthwash, Rashfree, Caladryl, Sloans Balm, etc.
Animal Health- It manufactures products for animal care namely Amoxisol, Vanguard 5/L, Stafac, Furea, Qualidrops, Catosal, Bayrocin, Nutrimilk, etc.
Awards
In March 2011 Pfizer ranked first in the medicine and health care industry in an annual ranking conducted by Antal International, a global executive search firm.
In 2010 December Pfizer France Wins Oncology Medical Affairs Best Practice Award.
In a survey conducted by Ernst & Young on customer satisfaction, Pfizer was ranked HIGH in terms of Overall Satisfaction with the Services and Interactions.
The company was acknowledged for its product Exubera with 'Innovative Products of the Year' at Pharma Excellence Awards 2006
It received the Silver Award for its printing advertising on Gelusil brand at the ABBY-All India Awards for Creative Excellence.

Market Cap: 12,189 Cr.
Current Price: 2,664
52 weeks High / Low 3840.00 / 2050.60
Book Value: 604.61
Stock P/E: 32.13
Dividend Yield: 0.75 %
ROCE: 21.48 %
ROE: 14.11 %
Sales Growth (3Yrs): 2.04 %
Listed on BSE and NSE
Company Website
Face Value: 10.00


Industry PBV:
EPS: 82.92
Graham: 1,062
Debt to equity: 0.00
Book value: 604.61
Price to Earning: 32.13
PEG Ratio: 2.71
Earning Power: 15.30 %
Return on equity: 14.11 %
Pledged percentage: 0.00 %
Intrinsic Value: 3,597
Industry PE:
Piotroski score: 6.00
Volume: 9,777
Market cap to quarterly profit: 127.24
Market Capitalization: 12,189 Cr.
Price to book value: 4.41
Return on assets: 13.87 %
Debt: 2.50 Cr.
Interest Coverage Ratio: 1,226
Promoter holding: 63.92 %
Unpledged promoter holding: 63.92 %
Sales last year: 1,969 Cr.